Thursday, June 16, 2016
Sharapova Appealed Against Two-Year Doping Ban
Russian Tennis Super star Sharapova has appealed to the court of Arbitration for Sport against her two-year doping ban. The 29-year-old tested positive for the controversial banned medication Meldonium duing January's Australian open. The ban announced by the International Tennis Federation is backdated to January 26, this year, when tested positive for the prohibited substance. In her appeal to CAS, Sharapova seeks annulment of the tribunal's decision to sanction her with a two year period of ineligibility further to an anti-doping rule violation. Ms Sharapova submits that the period of ineligibility should be eliminated or in the alternative, reduced. If her appeal is unsuccessful the five-time Grand Slam champion will miss the Olympic Gamed in Rio in August while the earliest Grand Slam she could next enter is French Open in August 2018. Sharapova blasted the ban as 'unfairly harsh' in a statement on her Facebook page. Meldonium was added to the world anti-doping WADA list on January 1. Sharapova said she has been using it for 10 years to help treat illness, a heart tissue and magnesium deficiency.